A septal myectomy is open-heart surgery to remove a strip of thickened muscle from the wall (septum) that divides the left and right ventricles, relieving an obstruction that blocks blood from flowing out of the heart. The operation is considered the gold standard treatment for people with hypertrophic cardiomyopathy (HCM) whose symptoms persist despite medication. At experienced centers, procedural mortality sits below one percent, and long-term survival after myectomy matches that of the general population.
Why the Septum Becomes a Problem
HCM is the most common inherited heart-muscle disorder, affecting roughly one in every two hundred people. In many cases the muscular wall between the ventricles grows abnormally thick, especially near the top of the septum where blood exits the left ventricle on its way to the aorta. That thickened ridge narrows the outflow tract. During each heartbeat, the fast-moving blood stream pulls the front leaflet of the mitral valve forward into the gap, a phenomenon called systolic anterior motion. The combination of the bulging septum and the displaced valve leaflet creates a significant pressure difference inside the ventricle, forcing the heart to work much harder to push blood out.1The American Journal of Cardiology. Mechanism of left ventricular outflow obstruction in patients with obstructive asymmetric septal hypertrophy (Idiopathic hypertrophic subaortic stenosis) People with this obstruction often experience breathlessness, chest pain, dizziness, and fainting spells, particularly during exertion.
Who Is a Candidate for Surgery
Medication is always the first step. Beta-blockers, calcium channel blockers, and the newer drug mavacamten can lower the pressure gradient and ease symptoms in many patients. Surgery enters the picture when drugs fail to provide adequate relief and the resting gradient across the outflow tract remains high, typically above 50 mmHg at rest or with provocation. “Provocation” matters here because some patients have only modest gradients while sitting quietly in a clinic but develop severe obstruction with everyday activities. In one surgical series, a third of the patients who underwent myectomy had minimal resting gradients but showed much worse obstruction when provoked by maneuvers like the Valsalva or during stress testing.2PubMed. Expanding the indications for septal myectomy in patients with hypertrophic cardiomyopathy: results of operation in patients with latent obstruction Recognizing these latent-obstruction patients is important because they can benefit just as much from surgery but might be overlooked if testing is done only at rest.
What Happens Before the Operation
Preoperative imaging drives the entire surgical plan. Echocardiography maps out where the septum is thickest, how much the mitral valve is being pulled into the outflow tract, and whether the papillary muscles or abnormal chords are contributing to the blockage. Cardiac MRI adds a three-dimensional view of the hypertrophy pattern that echocardiography can miss. Some centers have begun experimenting with virtual myectomy using CT-derived 3D models, essentially rehearsing the resection on a computer before the surgeon picks up a scalpel. In early testing this approach produced resection-volume estimates that closely matched what was actually removed in the operating room.
Once in the operating room, transesophageal echocardiography (a probe placed in the esophagus behind the heart) becomes the real-time guide. It is considered the standard of care for these cases, serving three roles at once: confirming the surgical target, monitoring blood flow during the procedure, and checking for complications the moment the heart restarts.3PubMed Central. Preintervention imaging and intraoperative management care of the hypertrophic obstructive cardiomyopathy patient
How the Surgery Is Performed
Septal myectomy is open-heart surgery performed through a median sternotomy, the vertical incision through the breastbone. The patient is placed on a heart-lung bypass machine so the heart can be stopped and opened. The surgeon gains access to the thickened septum through the aortic valve, looking down through the valve into the outflow tract below.
The classic version, often called the Morrow procedure after the surgeon who pioneered it, involves cutting a rectangular trough of muscle from the upper septum just below the aortic valve. The goal is to widen the channel enough that blood flows freely and the mitral valve no longer gets sucked into the gap. An extended version deepens and lengthens that resection toward the apex of the heart, addressing not just the upper bulge but a broader swath of thickened muscle.4PubMed Central. Comparison of Modified With Classic Morrow Septal Myectomy in Treating Hypertrophic Obstructive Cardiomyopathy The extended technique grew out of recognition that the classic operation sometimes left the lower part of the septal bulge untouched, which could allow residual obstruction.5Seminars in Thoracic and Cardiovascular Surgery: Pediatric Cardiac Surgery Annual. Surgical Technique of Extended Septal Myectomy
HCM anatomy varies enormously from person to person, so the operation is not a single cookie-cutter procedure. The surgeon must tailor the resection to each heart’s unique geography. Some patients have abnormal papillary muscles fused together or accessory chords tethering the mitral valve in ways that worsen obstruction. In those cases, the surgeon may release fused papillary muscles or trim anomalous chords in addition to removing septal muscle.6PubMed. Extended septal myectomy for hypertrophic obstructive cardiomyopathy with anomalous mitral papillary muscles or chordae Others require work on the mitral valve itself, techniques such as edge-to-edge repair or leaflet plication, when the valve’s own structure contributes to residual leaking or obstruction even after the septal muscle is removed.7Heart, Vessels and Transplantation. Mitral valve repair during septal myectomy in obstructive hypertrophic cardiomyopathy
Risks and Complications
Because the surgeon is cutting muscle in close proximity to the heart’s electrical conduction system, conduction disturbances are the most common complication. In a large series of nearly 2,500 patients, roughly four in ten who entered surgery with normal conduction developed a left bundle branch block afterward. Complete heart block, meaning the electrical signal from the upper chambers no longer reaches the lower chambers at all, occurred in about two percent of patients overall. The risk was far higher for those who already had a right bundle branch block going into surgery: about a third of that subgroup developed complete heart block and needed a permanent pacemaker.8PubMed. Conduction Abnormalities and Long-Term Mortality Following Septal Myectomy in Patients With Obstructive Hypertrophic Cardiomyopathy An earlier study confirmed that preexisting right bundle branch block was a strong predictor of needing a pacemaker soon after the operation.9PubMed. Early and late post-operative arrhythmias after surgical myectomy: 45 years of follow-up
A rarer but more serious complication is an iatrogenic ventricular septal defect, essentially a hole punched through the septum during resection. Most of these are caught immediately on echocardiography while the patient is still in the operating room and can be repaired on the spot. However, a septum that has been thinned aggressively can rupture days or weeks later, especially under the high pressures the left ventricle generates. Injury to a small artery feeding the septum during the resection may also cause a localized area of tissue death that weakens the wall over time.10PubMed Central. Late occurrence of ventricular septal rupture after deep septal myectomy for hypertrophic cardiomyopathy: Causes and management These delayed defects are uncommon but underscore why careful post-operative follow-up imaging matters.
How Well Does It Work
The gradient reduction is dramatic and immediate. Studies consistently show resting outflow gradients dropping from the range of 50 to 90 mmHg before surgery to single digits afterward, and those results hold years later.11PubMed Central. Results of surgical septal myectomy for obstructive hypertrophic cardiomyopathy: the Tufts experience12PubMed Central. Long-term outcomes and risk factors for mortality of patients with hypertrophic obstructive cardiomyopathy undergoing septal myectomy Symptom relief follows: in the Tufts series, 94 percent of patients improved to a functional class where they had no or only mild limitations on activity.
Survival after myectomy is equally striking. In a landmark Mayo Clinic study, ten-year survival after the operation was 83 percent, statistically identical to the general U.S. population matched by age and sex. Compared with patients who had obstructive HCM but did not undergo surgery, myectomy patients had markedly better survival at every time point, with a roughly 60 percent reduction in the risk of death.13PubMed. Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy There is also evidence that the operation reduces the risk of dangerous heart-rhythm events. Among patients with implantable defibrillators, those who had undergone myectomy experienced appropriate defibrillator shocks at a rate of only about 0.24 percent per year, compared with over four percent per year in the non-myectomy group.14European Heart Journal. Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy
That said, risk does not vanish entirely. Case reports document sudden cardiac death or dangerous arrhythmias occurring after successful myectomy, underscoring the importance of ongoing risk assessment even when the obstruction itself has been eliminated.15PubMed Central. Risk stratification for sudden cardiac death after septal myectomy
Quality of Life After Myectomy
Numbers on gradients and survival matter, but what patients tend to care about is whether they will feel better day to day. A prospective study that tracked quality of life using a validated questionnaire found that 92 percent of patients experienced a meaningful improvement by roughly fourteen months after surgery, and 80 percent saw a large improvement, defined as a jump of more than 20 points on a 100-point scale. At follow-up, 86 percent reported an excellent quality-of-life score.16PubMed Central. Association of Septal Myectomy With Quality of Life in Patients With Left Ventricular Outflow Tract Obstruction From Hypertrophic Cardiomyopathy Separate research has shown that both mental and physical well-being improve significantly in men and women alike.17PubMed Central. Improvement in Sexual Dysfunction in Patients With Hypertrophic Cardiomyopathy Undergoing Septal Myectomy: A Prospective Study For many patients, the improvement is transformative: people who could barely climb a flight of stairs return to exercising, working, and traveling without limitation.
Myectomy Versus Alcohol Septal Ablation
The main alternative to myectomy is alcohol septal ablation, a catheter-based procedure where alcohol is injected into a small artery feeding the thickened septum, deliberately causing a controlled heart attack that shrinks the muscle over time. It avoids open-heart surgery entirely, and its up-front complication rate is lower. A meta-analysis found fewer peri-procedural complications with ablation compared to myectomy (roughly six percent versus eleven percent).18PubMed Central. Alcohol Septal Ablation versus Septal Myectomy Treatment of Obstructive Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysis
The trade-offs become clearer with time. The same meta-analysis showed that ablation produced a smaller reduction in the outflow gradient and less symptom improvement than surgery. Patients who underwent ablation were far more likely to need a repeat procedure, with re-intervention rates above ten percent compared to under one percent for myectomy. Permanent pacemaker dependency was also about three times more common after ablation.18PubMed Central. Alcohol Septal Ablation versus Septal Myectomy Treatment of Obstructive Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysis On the question of long-term survival, the picture is mixed. A propensity-matched study found no statistically significant difference in death rates between the two approaches, though the trend favored myectomy and reintervention was vastly more common after ablation.19PubMed. Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy: A propensity score-matched cohort A larger registry-based analysis, however, found adjusted mortality remained higher after ablation even after accounting for age, sex, and other illnesses.20PubMed. Survival Following Alcohol Septal Ablation or Septal Myectomy for Patients With Obstructive Hypertrophic Cardiomyopathy
In practice, the choice often comes down to the individual patient. Ablation tends to be favored for older patients, those with significant surgical risk factors, or those who strongly prefer a less invasive approach. Myectomy is usually the first recommendation for younger, otherwise healthy patients who can tolerate open-heart surgery and who want the most complete, durable relief of their obstruction.
Why the Hospital Matters
Septal myectomy is a technically demanding operation performed on relatively few patients each year. Surgeon and hospital experience have a measurable effect on outcomes. A recent nationwide analysis found that low-volume operators had nearly double the odds of 30-day mortality compared to high-volume operators, and patients treated at low-volume hospitals faced a higher risk of being readmitted within 90 days.21PubMed Central. Procedural Volume and Outcomes After Septal Reduction Therapies in Hypertrophic Obstructive Cardiomyopathy A separate analysis of the Society of Thoracic Surgeons database confirmed that higher institutional case volume was associated with lower mortality, fewer ventricular septal defects, less heart block, and fewer unplanned mitral valve replacements.22PubMed. Impact of Hospital Volume on Outcomes of Septal Myectomy for Hypertrophic Cardiomyopathy
The concern runs deeper than just statistics. One editorial noted that a substantial proportion of myectomies performed at community hospitals involved concomitant valve replacements and iatrogenic septal defects, raising questions about whether some patients at these centers may not have truly had HCM or whether the operations were being performed by surgeons with insufficient experience.23The Journal of Thoracic and Cardiovascular Surgery. Why we need more septal myectomy surgeons: An emerging recognition For patients considering this surgery, seeking out a dedicated HCM center or a surgeon who performs myectomies regularly is one of the single most impactful decisions they can make.
Myectomy in Children and Adolescents
HCM can appear in childhood, sometimes in severe forms. The decision to operate on a child carries additional weight because the heart is still growing and the long-term stakes are higher. In a series of nearly 200 pediatric patients, myectomy reduced peak outflow gradients from a median of 50 mmHg to 4 mmHg immediately after the procedure, and that relief held at ten years. Operative mortality was about one percent. Iatrogenic valve injury occurred in a small proportion of cases but was repaired successfully each time. The need for a redo myectomy was low overall, but notably more common in children who had their first surgery before age two.24PubMed Central. Septal Myectomy Outcomes in Children and Adolescents With Obstructive Hypertrophic Cardiomyopathy Ten-year survival in this surgical cohort was 90 percent, substantially better than reported in pediatric HCM populations managed without surgery.
Age at surgery turns out to be one of the strongest predictors of whether the obstruction comes back. A study focused on young children and infants found that being under two years old at the time of surgery was strongly associated with residual or recurrent obstruction, likely because rapid cardiac growth can regenerate the thickened septum.25PubMed Central. Residual or recurrent obstruction after septal myectomy in young children and infants with hypertrophic cardiomyopathy: cohort study Having obstruction in both ventricles carried a similarly high risk. These findings shape how cardiologists counsel families: very young patients may need closer surveillance and, in some cases, a second surgery as they grow.
A separate consideration in pediatric HCM is whether to perform myectomy in a child who has obstruction but does not yet have classic symptoms. Some centers have explored the concept of prophylactic myectomy in this setting, reasoning that relieving obstruction early could prevent heart-muscle damage and sudden death. Published data support the procedure’s safety and late-survival benefit in children, though patient selection and surgical expertise remain critical when the immediate symptom burden is less clear-cut.26PubMed Central. Hypertrophic cardiomyopathy in children
The Evolving Surgical Approach
The operation has changed considerably since Andrew Morrow first described it in the 1960s. Early myectomies were relatively conservative, removing a shallow channel of muscle from just below the aortic valve. Surgeons gradually recognized that HCM pathology extends deeper than that upper ridge, involving midventricular muscle, abnormal papillary muscles, fibrous attachments, and sometimes bridges of muscle crossing over coronary arteries. The modern view treats myectomy less as a single standardized resection and more as a personalized reconstruction of the outflow tract, addressing whichever combination of abnormalities a given patient has. This tailored approach can be performed with very low mortality and morbidity at high-volume experienced centers.27PubMed Central. Transaortic septal myectomy: techniques and pitfalls
Emerging technology may push the boundaries further. Three-dimensional modeling and virtual myectomy allow surgeons to plan the exact volume of tissue to remove before they enter the chest, potentially reducing the risk of either too-aggressive or too-conservative resections. Robotic and minimally invasive approaches are being explored at a handful of centers, though they remain in early stages. Meanwhile, the introduction of mavacamten, a drug that targets the molecular engine of cardiac contraction, has added a new layer to the decision-making process. Some patients who would previously have been headed for surgery are now being stabilized on medication. Whether the drug merely delays surgery or genuinely replaces it in a subset of patients is a question cardiologists are actively tracking.